Senti Biosciences, Inc.

NasdaqCM:SNTI Stock Report

Market Cap: US$85.8m

Senti Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:SNTI Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Feb 25SellUS$6,074Kanya RajangamIndividual1,479US$4.37
06 Feb 25SellUS$18,339Timothy LuIndividual4,467US$4.36

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SNTI?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders222,6080.856%
Institutions1,014,6723.9%
Public Companies2,809,30510.8%
General Public8,405,16632.3%
VC/PE Firms13,552,61552.1%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 469%.

Top Shareholders

Top 24 shareholders own 67.68% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
37.6%
Celadon Partners
9,777,000US$32.3m0%no data
14.5%
New Enterprise Associates, Inc.
3,775,615US$12.5m753%0.63%
10.8%
Bayer Aktiengesellschaft
2,809,305US$9.3m378%no data
2.06%
Armistice Capital LLC
536,010US$1.8m0%0.04%
0.98%
8VC
253,755US$837.4k0%1.29%
0.62%
Timothy Lu
161,627US$533.4k0%no data
0.37%
The Vanguard Group, Inc.
97,467US$321.6k0%no data
0.2%
Renaissance Technologies LLC
51,600US$170.3k0%no data
0.13%
Kanya Rajangam
33,000US$108.9k0%no data
0.11%
Geode Capital Management, LLC
27,494US$90.7k0.74%no data
0.073%
UBS Asset Management AG
18,969US$62.6k80.7%no data
0.068%
James Collins
17,613US$58.1k0%no data
0.051%
Virtu Financial LLC, Asset Management Arm
13,356US$44.1k0%no data
0.04%
Donald F. Tang
10,368US$34.2k0%no data
0.038%
State Street Global Advisors, Inc.
10,010US$33.0k0%no data
0.015%
BlackRock, Inc.
4,004US$13.2k0%no data
0.0039%
Tower Research Capital Europe Limited
1,023US$3.4k-56.6%no data
0.0013%
SBI Holdings Inc., Asset Management Arm
338US$1.1k0.3%no data
0.0012%
Dimensional Fund Advisors LP
307US$1.0k0%no data
0.00062%
Morgan Stanley, Investment Banking and Brokerage Investments
160US$532.0-71.7%no data
0.00046%
Bank of America Corporation, Asset Management Arm
120US$394.7-65.8%no data
0.00012%
Barclays Bank PLC, Securities Investments
30US$103.0-94%no data
0.00011%
ARK Investment Management LLC
28US$94.4-100%no data
0%
Citigroup Inc.,Banking and Securities Investments
1US$0-99.4%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/07 06:43
End of Day Share Price 2025/05/07 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Senti Biosciences, Inc. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gregory HarrisonBofA Global Research
Yevgeniya LivshitsChardan Capital Markets, LLC
Lut Ming ChengJ.P. Morgan